DLIClass I
Acetylcholine Chloride, Specific Reagent For Pseudo Cholinesterase
21 CFR 862.3240 / Clinical Toxicology
DLI is the FDA product code for Acetylcholine Chloride, Specific Reagent For Pseudo Cholinesterase, a class I device type, regulated under 21 CFR 862.3240. As of , FDA records hold 6 510(k) clearances under this code, the most recent dated , and no recalls.
Classification record
- Product code
- DLI
- Device name
- Acetylcholine Chloride, Specific Reagent For Pseudo Cholinesterase
- Regulation
- 21 CFR 862.3240
- Device class
- Class I
- Review panel
- Clinical Toxicology
- Submission type
- 510(k) exempt
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 6
- Ingested recalls
- 0
Clearances, product code DLI
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 1977 | 1 |
| 1983 | 1 |
| 1986 | 2 |
| 1993 | 1 |
| 1995 | 1 |
Applicants with the most clearances
Product code DLI| Applicant | Clearances |
|---|---|
| American Monitor Corp. | 1 |
| E.I. Dupont de Nemours & Co., Inc. | 1 |
| Em Diagnostic Systems, Inc. | 1 |
| Kulzer GmbH | 1 |
| Sterling Biochemical, Inc. | 1 |
| Sterling Diagnostics, Inc. | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
